Bin Gui is a Principal Scientist at Entact Bio, leading mechanistic biology for a preclinical heterobifunctional small molecule program focused on a rare metabolic disorder. Previously, Bin Gui served as Principal Scientist at Ribon Therapeutics, where contributions included co-leading platform initiatives, leading target validation teams, and managing CROs to evaluate oncology drug targets. Bin Gui's extensive experience includes establishing innovative screening methodologies during roles as Senior Scientist and Scientist at Ribon Therapeutics and conducting significant research as a Postdoctoral Research Fellow at prestigious institutions such as Harvard Medical School and Brigham and Women's Hospital. Bin Gui holds a Ph.D. in Biochemistry and Molecular Biology and a Bachelor of Medical Science, both from Peking University.
This person is not in any teams
This person is not in any offices